Biological Role of Dystroglycan in Schwann Cell Function and Its Implications in Peripheral Nervous System Diseases

被引:18
|
作者
Masaki, Toshihiro [1 ,2 ]
Matsumura, Kiichiro [3 ]
机构
[1] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4SB, Midlothian, Scotland
[2] Teikyo Univ Sci, Fac Med Sci, Adachi Ku, Tokyo 1200045, Japan
[3] Teikyo Univ, Dept Neurol & Neurosci, Itabashi Ku, Tokyo 1738605, Japan
关键词
CONGENITAL MUSCULAR-DYSTROPHY; LAMININ ALPHA-2 CHAIN; PERIAXIN MUTATIONS CAUSE; FOCAL ADHESION KINASE; DOMAIN-BINDING MOTIF; BETA-DYSTROGLYCAN; GLYCOPROTEIN COMPLEX; EXTRACELLULAR-MATRIX; SKELETAL-MUSCLE; TYROSINE PHOSPHORYLATION;
D O I
10.1155/2010/740403
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Dystroglycan is a central component of the dystrophin-glycoprotein complex (DGC) that links extracellular matrix with cytoskeleton, expressed in a variety of fetal and adult tissues. Dystroglycan plays diverse roles in development and homeostasis including basement membrane formation, epithelial morphogenesis, membrane stability, cell polarization, and cell migration. In this paper, we will focus on biological role of dystroglycan in Schwann cell function, especially myelination. First, we review the molecular architecture of DGC in Schwann cell abaxonal membrane. Then, we will review the loss-of-function studies using targeted mutagenesis, which have revealed biological functions of each component of DGC in Schwann cells. Based on these findings, roles of dystroglycan in Schwann cell function, in myelination in particular, and its implications in diseases will be discussed in detail. Finally, in view of the fact that understanding the role of dystroglycan in Schwann cells is just beginning, future perspectives will be discussed.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Tenascin-R is expressed by Schwann cells in the peripheral nervous system
    Probstmeier, R
    Nellen, J
    Gloor, S
    Wernig, A
    Pesheva, P
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2001, 64 (01) : 70 - 78
  • [42] Peripheral Nervous System (PNS) Myelin Diseases
    Scherer, Steven S.
    Svaren, John
    [J]. COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2024, 16 (05):
  • [43] Diagnosis of monogenic diseases of the peripheral nervous system
    Haupt, A
    Epplen, JT
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 121 (47) : 1469 - 1472
  • [44] Gene therapy for peripheral nervous system diseases
    Federici, Thais
    Boulis, Nicholas
    [J]. CURRENT GENE THERAPY, 2007, 7 (04) : 239 - 248
  • [45] DISEASES OF THE PERIPHERAL NERVOUS-SYSTEM IN THE PREGNANT
    LOBZIN, VS
    ZHULEV, NM
    RYZHKOV, VD
    [J]. VRACHEBNOE DELO, 1989, (11): : 88 - 90
  • [46] Peripheral nervous system manifestations of rheumatological diseases
    Gwathmey, Kelly G.
    Satkowiak, Kelsey
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 424
  • [47] The peripheral nervous system and the pathogenesis of prion diseases
    Glatzel, M
    Giger, O
    Braun, N
    Aguzzi, A
    [J]. CURRENT MOLECULAR MEDICINE, 2004, 4 (04) : 355 - 359
  • [48] Peripheral Nervous System Manifestations of Infectious Diseases
    Brizzi, Kate T.
    Lyons, Jennifer L.
    [J]. NEUROHOSPITALIST, 2014, 4 (04): : 230 - 240
  • [49] THE STRUCTURE OF PERIPHERAL NERVOUS-SYSTEM DISEASES
    TIKK, AA
    VIRRO, TE
    PYLLUMAA, RY
    [J]. ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 1983, 83 (08): : 1165 - 1168
  • [50] Inflammatory diseases of the peripheral nervous system and muscles
    von Klopmann, Thilo
    Tipold, Andrea
    [J]. MAGYAR ALLATORVOSOK LAPJA, 2008, 130 (05) : 270 - 273